OREANDA-NEWS. September 19, 2011. The world market of medicines for the needs of public health and veterinary medicine at this time is estimated at 850 billion dollars. This industry is capital intensive, science-intensive and requires a large number of highly qualified and also stimulates the development of many related industries.

This was stressed by the Head of the State Agency for Science, Innovation and Informatization of Ukraine Volodymyr Semynozhenko during a meeting of scientific and technical council of the National Target Scientific and Technical Program Development of new technologies create domestic pharmaceuticals for human health and the needs of veterinary medicine at 2011-2015.

According to the Head of the State Agency for Science, Innovation and Informatization, a key element of the pharmaceutical industry is the system of development of innovative drugs, which creates the necessary conditions for the organization, development and use of drugs. In highly developed countries (USA, Japan) and rapidly developing countries (China, India), construction and development of an integrated system of developing their own drugs is considered one of the main objectives. Ukraine hasn’t such system - domestic pharmaceutical companies are almost entirely focused on manufacturing generics. This situation is negative in terms of the need to preserve the nation's health, biological, economic and, in general, national security and should resolve as soon as possible.

The participants discussed and approved the provision of scientific and technical council of the National Target Scientific and Technical Program Development of new technologies create domestic pharmaceuticals for human health and veterinary medicine needs for 2011-2015, and identified managers of tasks of the program who will ensure coordination of its activities.